Nivolumab, Pomalidomide, and Elotuzumab Combination Regimens for Treatment of Relapsed and Refractory Multiple Myeloma: Results from the Phase 3 CheckMate 602 Study
Article in Clinical Lymphoma Myeloma & Leukemia (May 2024)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
Article in Clinical Lymphoma Myeloma & Leukemia (May 2024)
Article in Blood (August 2023)
Article in Haematologica (July 2023)